/Investor DB

Vertical Venture Partners — 2020 Investments

2 investments dated 2020 · listed companies and verified rows first · show all

Basilard BioTechbasilardbiotech.cominMar 2020

Basilard BioTech develops Celletto, a nanomechanical (mechanoporation) gene delivery platform that inserts genes directly into the nucleus of cells without viral vectors, aimed at cell and gene therapy (CGT) developers and manufacturers.

BiotechDeep TechMedical Devices

Co-investorsBand of AngelsGENERAL INCEPTIONPaladin Capital Group

Ziparizipari.comin𝕏Jan 2020 · $22.5M

Zipari, now part of mPulse, provides digital member and provider portals for health plans and third-party administrators (TPAs).

Digital HealthHealthtechInsurTechSaaSNew York, US

Mark Nathan(Executive Officer, Director)

BoardDavid Schwab(Director)in

Co-investorsHealth Velocity Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.